Related Experiment Video
Updated: Jul 3, 2026
07:49
A Pacing-Controlled Procedure for the Assessment of Heart Rate-Dependent Diastolic Functions in Murine Heart Failure Models
Published on: July 21, 2023
Reduction in Heart Failure Hospitalizations Through Real-World HeartLogicTM Alert Response - A Multicenter Study in
Takafumi Oka1, Mitsuyoshi Takahara2, Shohei Kataoka3
1Department of Cardiovascular Medicine, the University of Osaka Graduate School of Medicine.
Summary
Responding to HeartLogic alerts may reduce heart failure hospitalizations. This real-world study found that timely alert responses significantly attenuated the increase in heart failure hospitalizations over time.
Area of Science:
- Cardiology
- Medical Technology
- Health Services Research
Background:
- Heart failure (HF) is a progressive condition with increasing hospitalization rates.
- HeartLogic (HL) is a remote monitoring system for early detection of HF decompensation.
- Real-world data is needed to assess the impact of HL alert responses on HF hospitalizations.
Purpose of the Study:
- To evaluate if responses to HeartLogic alerts can reduce HF-related hospitalizations.
- To compare HF hospitalization rates before and after HL alert activation.
- To assess the impact of alert responsiveness on hospitalization trends.
Main Methods:
- Retrospective analysis of 246 patients with HL-enabled devices across 8 Japanese centers.
- Categorization of patients into alert-responsive (AR) and non-responsive (NR) groups.
- Comparison of HF hospitalization rates during alert-off and alert-on periods.
Main Results:
- HF hospitalizations increased from 77.1 to 182.6 per 1,000 person-years after alert activation.
- The increase in HF hospitalizations was significantly higher in the NR group (3.24-fold) compared to the AR group (1.28-fold).
- Alert responsiveness significantly attenuated the relative increase in HF hospitalizations (adjusted relative ratio 0.40; P=0.025).
Conclusions:
- Real-world alert responses to HeartLogic may reduce HF hospitalizations.
- Proactive management of HF decompensation through alert responses can potentially lower healthcare costs.
- This study highlights the clinical utility of remote monitoring systems in managing chronic diseases like heart failure.
Related Concept Videos
01:30Heart Failure V: Medical Management
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
01:22Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
01:26Heart Failure III: Clinical Manifestations
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
01:29Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
01:21Rheumatic Heart Disease III: Medical Management
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...